EGFR mutations and molecularly targeted therapy:: a new era in the treatment of lung cancer

被引：15
|
作者：
Dowell, JE
Minna, JD
机构：
[1] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA
[2] Dallas VA Med Ctr, Dallas, TX USA
[3] Univ Texas, SW Med Ctr, Ctr Canc Genet, Dallas, TX USA
[4] Univ Texas, SW Med Ctr, NCI Special Program Res Excellence, Dallas, TX USA
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2006年 / 3卷 / 04期
关键词：
D O I：
10.1038/ncponc0476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：170 / 171
页数：2
相关论文
共 50 条
  • [41] Gemcitabine-Loaded EGFR Aptamer for Targeted Therapy of Lung Cancer
    Park, Jun Young
    Chu, Ga Eul
    Cho, Ye Lim
    Cho, Won Gil
    Kang, Won Jun
    MOLECULAR THERAPY, 2019, 27 (04) : 361 - 361
  • [42] Gemcitabine-loaded EGFR aptamer for targeted therapy of lung cancer
    Park, Jun Young
    Cho, Ye Lim
    Chae, Ju Ri
    Kang, Won Jun
    CANCER RESEARCH, 2023, 83 (07)
  • [43] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
    Paez, JG
    Jänne, PA
    Lee, JC
    Tracy, S
    Greulich, H
    Gabriel, S
    Herman, P
    Kaye, FJ
    Lindeman, N
    Boggon, TJ
    Naoki, K
    Sasaki, H
    Fujii, Y
    Eck, MJ
    Sellers, WR
    Johnson, BE
    Meyerson, M
    SCIENCE, 2004, 304 (5676) : 1497 - 1500
  • [44] Resistance to molecularly targeted therapy in non-small-cell lung cancer
    Asao, Tetsuhiko
    Takahashi, Fumiyuki
    Takahashi, Kazuhisa
    RESPIRATORY INVESTIGATION, 2019, 57 (01) : 20 - 26
  • [45] Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment
    Zhang, Tian
    George, Daniel J.
    NATURE MEDICINE, 2021, 27 (04) : 586 - 588
  • [46] Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment
    Tian Zhang
    Daniel J. George
    Nature Medicine, 2021, 27 : 586 - 588
  • [47] Pancreatic cancer EGFR pathway signaling in the absence of activating mutations: Implications for EGFR-targeted therapy
    Tzeng, Ching-Wei D.
    Frolov, Andrey
    Frolova, Natalya
    Jhala, Nirag C.
    Frost, Andra R.
    Howard, J. Harrison
    Schuller, Kyle W.
    Buchsbaum, Donald J.
    Vickers, Selwyn M.
    Heslin, Martin J.
    Arnoletti, J. Pablo
    CANCER RESEARCH, 2006, 66 (08)
  • [48] EGFR AMPLIFICATIONS AND MUTATIONS IN LUNG CANCER
    Isaksson, Sofi
    Salomonsson, Annette
    Bendahl, Par-Ola
    Johansson, Leif
    Jonsson, Per
    Jonsson, Mats
    Jonsson, Goran
    Planck, Maria
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3327 - 3328
  • [49] Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era
    Xiaohong Xie
    Guihuan Qiu
    Ziyao Chen
    Ting Liu
    Yilin Yang
    Zhixuan You
    Chen Zeng
    Xinqing Lin
    Zhanhong Xie
    Yinyin Qin
    Yansheng Wang
    Xiaodong Ma
    Chengzhi Zhou
    Ming Liu
    Clinical and Translational Oncology, 2024, 26 : 434 - 445
  • [50] Molecularly targeted approaches to the chemoprevention of lung cancer
    Khuri, FR
    Cohen, V
    CLINICAL CANCER RESEARCH, 2004, 10 (12) : 4249S - 4253S
12345